Literature DB >> 21075370

Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal women.

Muhammad Faisal Aslam1, Zaher O Merhi, Safaa Ahmed, Oumar Kuzbari, David B Seifer, Howard Minkoff.   

Abstract

Eight premenopausal women with cancer had blood drawn for analysis of brain-derived neurotrophic factor (BDNF) and müllerian-inhibiting substance (MIS) before and 3 months after receiving chemotherapy. Unlike MIS, BDNF levels were not reduced after chemotherapy.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21075370      PMCID： PMC3047594          DOI： 10.1016/j.fertnstert.2010.10.033

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  29 in total

1.  Human platelets contain brain-derived neurotrophic factor.

Authors:  H Yamamoto; M E Gurney
Journal:  J Neurosci       Date:  1990-11       Impact factor: 6.167

2.  Ovarian brain-derived neurotrophic factor is present in follicular fluid from normally cycling women.

Authors:  David B Seifer; Geralyn Lambert-Messerlian; Alan L Schneyer
Journal:  Fertil Steril       Date:  2003-02       Impact factor: 7.329

3.  Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound.

Authors:  L E Bath; W H B Wallace; M P Shaw; C Fitzpatrick; R A Anderson
Journal:  Hum Reprod       Date:  2003-11       Impact factor: 6.918

Review 4.  The effects of radiotherapy and chemotherapy on female reproduction.

Authors:  D Meirow; D Nugent
Journal:  Hum Reprod Update       Date:  2001 Nov-Dec       Impact factor: 15.610

5.  Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results.

Authors:  Christine Decanter; Franck Morschhauser; Pascal Pigny; Catherine Lefebvre; Cécile Gallo; Didier Dewailly
Journal:  Reprod Biomed Online       Date:  2009-12-03       Impact factor: 3.828

6.  Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles.

Authors:  David B Seifer; David T MacLaughlin; Benjamin P Christian; Bo Feng; Robert M Shelden
Journal:  Fertil Steril       Date:  2002-03       Impact factor: 7.329

7.  Brain-derived neurotrophic factor: a novel human ovarian follicular protein.

Authors:  David B Seifer; Bo Feng; Robert M Shelden; Shiling Chen; Cheryl F Dreyfus
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

8.  Diminished ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH <10 IU/l.

Authors:  E C Larsen; J Müller; C Rechnitzer; K Schmiegelow; A Nyboe Andersen
Journal:  Hum Reprod       Date:  2003-02       Impact factor: 6.918

9.  Neurotrophin-4/5 and neurotrophin-3 are present within the human ovarian follicle but appear to have different paracrine/autocrine functions.

Authors:  David B Seifer; Bo Feng; Robert M Shelden; Shiling Chen; Cheryl F Dreyfus
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

10.  Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

Authors:  Christien Weenen; Joop S E Laven; Anne R M Von Bergh; Mark Cranfield; Nigel P Groome; Jenny A Visser; Piet Kramer; Bart C J M Fauser; Axel P N Themmen
Journal:  Mol Hum Reprod       Date:  2004-02       Impact factor: 4.025
View more
  2 in total

Review 1.  Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic review.

Authors:  Maëliss Peigné; Christine Decanter
Journal:  Reprod Biol Endocrinol       Date:  2014-03-26       Impact factor: 5.211

Review 2.  Neurotrophins and glial cell line-derived neurotrophic factor in the ovary: physiological and pathophysiological implications.

Authors:  Hsun-Ming Chang; Hai-Cui Wu; Zhen-Gao Sun; Fang Lian; Peter C K Leung
Journal:  Hum Reprod Update       Date:  2019-03-01       Impact factor: 15.610
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.